Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Eli Lilly and Company
Pfizer
Eli Lilly and Company
AbbVie
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
BBB-Therapeutics B.V.
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Novartis
Tufts Medical Center
National Institutes of Health Clinical Center (CC)